← Back to Search

Telerehabilitation for Stroke

N/A
Recruiting
Led By Preeti Raghavan, MD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
For treatment group: visual deficit such as deficit in visual acuity, eye movements, visual field cut, or neglect, medical comorbidity such as other neurological conditions (e.g. Parkinson's disease, brain tumor, epilepsy), or previous injury to the upper limb, pain in the upper limbs that prevents full passive range of motion to perform the exercises
For control group: visual deficit such as deficit in visual acuity, eye movements, visual field cut, or neglect, any previous injury or medical condition that prevents full passive range of motion to perform the exercises
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights
No Placebo-Only Group

Summary

This trial is looking at ways to use technology to help people with stroke recover by making it more social. They will be testing if competition or cooperation is more effective in helping people recover.

Who is the study for?
This trial is for stroke survivors with hemiparesis for over 3 months, who can sit or stand on their own, have basic cognitive skills and technical interest. They should have limited arm movement but full passive range of motion. The control group requires no learning disabilities and an interest in using internet platforms.
What is being tested?
The study tests upper limb tele-rehabilitation through a haptic device and online platform by comparing competition, cooperation, and isolation strategies in social interaction. It measures rehabilitation performance, motivation to contribute to science tasks, and emotional well-being.
What are the potential side effects?
Since this is a non-drug intervention focusing on rehabilitation exercises via technology, traditional medication side effects are not expected. However, participants may experience fatigue or frustration related to the use of the rehabilitation devices or platform.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have vision problems or other health issues that might affect my participation.
Select...
I have a visual problem or a condition that limits my movement for exercises.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Fugl-Meyer scale
Video-based motion analysis
assessment of tone using Ashworth scale

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Stroke PatientsExperimental Treatment2 Interventions
Group II: Healthy ControlsActive Control2 Interventions

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,327 Previous Clinical Trials
14,874,574 Total Patients Enrolled
39 Trials studying Stroke
33,212 Patients Enrolled for Stroke
National Science FoundationUNKNOWN
2 Previous Clinical Trials
23 Total Patients Enrolled
Preeti Raghavan, MDPrincipal InvestigatorJohns Hopkins University
5 Previous Clinical Trials
178 Total Patients Enrolled
4 Trials studying Stroke
132 Patients Enrolled for Stroke

Media Library

Output-Focus Condition Clinical Trial Eligibility Overview. Trial Name: NCT03096262 — N/A
Stroke Research Study Groups: Healthy Controls, Stroke Patients
Stroke Clinical Trial 2023: Output-Focus Condition Highlights & Side Effects. Trial Name: NCT03096262 — N/A
Output-Focus Condition 2023 Treatment Timeline for Medical Study. Trial Name: NCT03096262 — N/A
~1 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top